Orakl Oncology has an AIxBio platform that is unique because it captures signals from six dimensions of life. They believe it gives their model high predictive accuracy
- Jun 3
- 1 min read
Co-Founder & CEO Fanny Jaulin describes the platform, which integrates data from DNA, RNA, proteins, cells, tissues, and real world patient data. They are starting with pancreatic and colorectal cancer and believe their database for these cancers is the largest of its kind.
.png){kind=logo}